Hemalex.bio hemalex.bio is an executive biotech advisory firm supporting advanced therapy, vaccine, and biologics companies with CMC strategy, GMP manufacturing, and clinical supply chain design. The firm provides interim quality and operations leadership, builds inspection-ready QMS frameworks, conducts CDMO audits and supplier qualification, and structures EU/US regulatory pathways from early development through commercialization. With deep expertise in ATMPs, mRNA, gene and cell therapy platforms, hemalex.bio de-risks development programs, strengthens transaction readiness, and aligns science with scalable, compliant execution. Consulting Firm  |